N4 Pharma plc (AIM: N4P)*: New CEO, new name and new strategyOne Health Group plc (AIM: OHGR): Planning sign off and commencement of Surgical Hub constructionOptiBiotix Health plc (AIM: OPTI): Clinical trial to evaluate the effect of WellBiome® on surgical outcomes and NHS cost savings
24 Feb 2026
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
OptiBiotix Health PLC (OPTI:LON), 0 | One Health Group PLC (OHGR:LON), 0 | Thalia Therapeutics PLC (THAT:LON), 0
- Published:
24 Feb 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
4 -
N4 Pharma plc (AIM: N4P)*: New CEO, new name and new strategyOne Health Group plc (AIM: OHGR): Planning sign off and commencement of Surgical Hub constructionOptiBiotix Health plc (AIM: OPTI): Clinical trial to evaluate the effect of WellBiome® on surgical outcomes and NHS cost savings